Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain

Journal of Neuroimmunology

Volumn 223, Issue 1-2, 2010, Pages 100-103

  Swaminathan, Bhairavi ^a   Matesanz, Fuencisla ^b   Cavanillas, Mariá L ^c   Alloza, Iraide ^a   Otaegui, David ^d   Olascoaga, Javier ^e   Cénit, María C ^c   Heras, Virgina de las ^c   Barcina, María García ^f   Arroyo, Rafael ^c   Alcina, Antonio ^b   Fernandez, Oscar ^g   Antigüedad, Alfredo ^h   Urcelay, Elena ^c   Vandenbroeck, Koen ^a,i  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^e HOSPITAL DONOSTIA   (Spain)

^f Servicio de Genética   (Spain)

^g HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^h HOSPITAL DE BASURTO   (Spain)

ⁱ BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

Genetics CD6; Genomics; IRF8 polymorphism; Multiple sclerosis; Susceptibility; TNFRSF1A

Indexed keywords

CD6 ANTIGEN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 1A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EXON; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; UPREGULATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; EUROPE; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 77953538361     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.03.020     Document Type: Article

References (23)

1. ANZgene Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet. 2009, 41:824-828.
2. Arman M., Aguilera-Montilla N., Mas V., Puig-Kröger A., Pignatelli M., Guigó R., Corbi A.L., Lozano F. The human CD6 gene is transcriptionally regulated by RUNX and Ets transcription factors in T cells. Mol. Immunol. 2009, 46:2226-2235.
3. Ban M., Goris A., Lorentzen A.R., Baker A., Mihalova T., Ingram G., Booth D.R., Heard R.N., Stewart G.J., Bogaert E., Dubois B., Harbo H.F., Celius E.G., Spurkland A., Strange R., Hawkins C., Robertson N.P., Dudbridge F., Wason J., De Jager P.L., Hafler D., Rioux J.D., Ivinson A.J., McCauley J.L., Pericak-Vance M., Oksenberg J.R., Hauser S.L., Sexton D., Haines J., Sawcer S. Wellcome Trust Case-Control Consortium (WTCCC), Compston A. Eur. J. Hum. Genet. 2009, 17:1309-1313.
4. Bowen M.A., Whitney G.S., Neubauer M., Starling G.C., Palmer D., Zhang J., Nowak N.J., Shows T.B., Aruffo A. Structure and chromosomal location of the human CD6 Gene: fetection of five human CD6 isoforms. J. Immunol. 1997, 158(3):1149-1156.
5. Castro M.A., Oliveira M.I., Nunes R.J., Fabre S., Barbosa R., Peixoto A., Brown M.H., Parnes J.R., Bismuth G., Moreira A., Rocha B., Carmo A.M. Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapse. J. Immunol. 2007, 178:4351-4361.
6. De Jager P.L., Baecher-Allan C., Maier L.M., Arthur A.T., Ottoboni L., Barcellos L., McCauley J.L., Sawcer S., Goris A., Saarela J., Yelensky R., Price A., Leppa V., Patterson N., de Bakker P.I., Tran D., Aubin C., Pobywajlo S., Rossin E., Hu X., Ashley C.W., Choy E., Rioux J.D., Pericak-Vance M.A., Ivinson A., Booth D.R., Stewart G.J., Palotie A., Peltonen L., Dubois B., Haines J.L., Weiner H.L., Compston A., Hauser S.L., Daly M.J., Reich D., Oksenberg J.R., Hafler D.A. The role of the CD58 locus in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5264-5269.
7. De Jager P.L., Jia X., Wang J., de Bakker P.I., Ottoboni L., Aggarwal N.T., Piccio L., Raychaudhuri S., Tran D., Aubin C., Briskin R., Romano S., Baranzini S.E., McCauley J.L., Pericak-Vance M.A., Haines J.L., Gibson R.A., Naeglin Y., Uitdehaag B., Matthews P.M., Kappos L., Polman C., McArdle W.L., Strachan D.P., Evans D., Cross A.H., Daly M.J., Compston A., Sawcer S.J., Weiner H.L., Hauser S.L., Hafler D.A., Oksenberg J.R. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 2009, 41:776-782.
8. Fromont A., De Seze J., Fleury M.C., Maillefert J.F., Moreau T. Inflammatory demyelinating events following treatment with anti-tumor necrosis factor. Cytokine 2009, 45:55-57.
9. Gregory S.G., Schmidt S., Seth P., Oksenberg J.R., Hart J., Prokop A., Caillier S.J., Ban M., Goris A., Barcellos L.F., Lincoln R., McCauley J.L., Sawcer S.J., Compston D.A., Dubois B., Hauser S.L., Garcia-Blanco M.A., Pericak-Vance M.A., Haines J.L. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat. Genet. 2007, 39:1053-1054.
10. Hassan N.J., Simmonds S.J., Clarkson N.G., Hanrahan S., Puklavec M.J., Bomb M., Barclay A.N., Brown M.H. CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76. Mol. Cell. Biol. 2006, 26:6727-6738.
11. IMSGC, Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., de Bakker P.I., Gabriel S.B., Mirel D.B., Ivinson A.J., Pericak-Vance M.A., Gregory S.G., Rioux J.D., McCauley J.L., Haines J.L., Barcellos L.F., Cree B., Oksenberg J.R., Hauser S.L. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 2007, 357:851-862.
12. Johnson, B.A., Wang, J., Taylor, E.M., Caillier, S.J., Herbert, J., Khan, O.A., Cross, A.H., De Jager, P.L., Gourraud, P.A., Cree, B.C., Hauser, S.L., Oksenberg, J.R., in press. Multiple sclerosis susceptibility alleles in African Amercans. Genes Immun. http://doi:10.1038/gene.2009.81.
13. Kümpfel T., Hoffmann L.A., Pellkofer H., Pöllmann W., Feneberg W., Hohlfeld R., Lohse P. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases. Neurology 2008, 25:1812-1820.
14. Kümpfel T., Hohfeld R. Multiple sclerosis. TNFRSF1A, TRAPS and multiple sclerosis. Nat. Rev. Neurol. 2009, 5:528-529.
15. Lundmark F., Duvefelt K., Iacobaeus E., Kockum I., Wallstrom E., Khademi M., Oturai A., Ryder L.P., Saarela J., Harbo H.F., Celius E.G., Salter H., Olsson T., Hillert J. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 2007, 39:1108-1113.
16. Matesanz F., Caro-Maldonado A., Fedetz M., Fernandez O., Milne R.L., Guerrero M., Delgado C., Alcina A. IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility. J. Neurol. 2007, 254:682-684.
17. Mero, I.L., Lorentzen, A.R., Ban, M., Smestad, C., Celius, E.G., Aarseth, J.H., Myhr, K.M., Link, J., Hillert, J., Olsson, T., Kockum, I., Masterman, T., Oturai, A.B., Søndergaard, H.B., Sellebjerg, F., Saarela, J., Kemppinen, A., Elovaara, I., Spurkland, A., Dudbridge, F., Lie, B.A., Harbo, H.F., 2010. A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. Eur. J. Hum. Genet. 18, 502-504.
18. O'Doherty C., Kantarci O.H., Vandenbroeck K. IL7RA polymorphisms and susceptibility to multiple sclerosis. N. Engl. J. Med. 2008, 358:753-754.
19. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983, 13:227-231.
20. Sarrias M.R., Farnós M., Mota R., Sánchez-Barbero F., Ibáñez A., Gimferrer I., Vera J., Fenutría R., Casals C., Yélamos J., Lozano F. CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock. Proc. Natl Acad. Sci. USA 2007, 104:11724-11729.
21. Skol A.D., Scott L.J., Abecasis G.R., Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 2006, 38:209-213.
22. van Oosten B.W., Barkhof F., Truyen L., Boringa J.B., Bertelsmann F.W., von Blomberg B.M., Woody J.N., Hartung H.P., Polman C.H. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 1996, 47:1531-1534.
23. Zoledziewska M., Costa G., Pitzalis M., Cocco E., Melis C., Moi L., Zavattari P., Murru R., Lampis R., Morelli L., Poddie F., Frongia P., Pusceddu P., Bajorek M., Marras A., Satta A.M., Chessa A., Pugliatti M., Sotgiu S., Whalen M.B., Rosati G., Cucca F., Marrosu M.G. Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia. Genes Immun. 2008, 10:15-17.